Any trial in which RT (of any kind) was the primary treatment
comparison after BCS.
This included: BCS (either lumpectomy, quadrantectomy, or segmental
mastectomy) with or without RT (any standard schedule
of treatment).
Trials where patients received tamoxifen were included provided
this was given in both study arms and patients differed only in
respect to receiving radiotherapy or not.